Cargando…

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project

Mostrar otras versiones (1)

INTRODUCTION: Several vaccines against SARS-CoV-2 are currently in use and are recommended in inflammatory bowel disease (IBD) patients. Data are scarce about the gastroenterologists and IBD patient's acceptance of SARS-CoV-2 vaccines. The aim of the study was to evaluate the intention to get v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreiro-Iglesias, Rocío, Hernández-Camba, Alejandro, Serrano Labajos, Ruth, Rodríguez-Lago, Iago, Zabana, Yamile, Barreiro-de Acosta, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386133/ https://www.ncbi.nlm.nih.gov/pubmed/34453969 http://dx.doi.org/10.1016/j.gastrohep.2021.08.004

Ejemplares similares

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
por: Ferreiro-Iglesias, Rocío, et al.
Publicado: (2022)

Diagnosis and natural history of preclinical and early inflammatory bowel disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

COVID-19 and inflammatory bowel disease: Questions arising from patient care and follow-up during the initial phase of the pandemic (February–April 2020)()
por: Marín-Jiménez, Ignacio, et al.
Publicado: (2020)

COVID-19 y enfermedad inflamatoria intestinal: preguntas surgidas de la atención y seguimiento de los pacientes durante la fase inicial de la pandemia (febrero-abril 2020)
por: Marín-Jiménez, Ignacio, et al.
Publicado: (2020)

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
por: Hernández Camba, Alejandro, et al.
Publicado: (2022)

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
por: Hernández Camba, Alejandro, et al.
Publicado: (2022)

Role of Quality of Life as Endpoint for Inflammatory Bowel Disease Treatment
por: Calviño-Suárez, Cristina, et al.
Publicado: (2021)

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience
por: Barreiro‐de Acosta, Manuel, et al.
Publicado: (2021)

Methotrexate in inflammatory bowel disease: A primer for gastroenterologists
por: AlAmeel, Turki, et al.
Publicado: (2022)

Recent Advances and Potential Multi-Omics Approaches in the Early Phases of Inflammatory Bowel Disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2023)

Variations in the medical treatment of inflammatory bowel disease among gastroenterologists
por: Singh, Shailendra, et al.
Publicado: (2018)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult Gastroenterologist
por: Trivedi, Itishree, et al.
Publicado: (2015)

Gastroenterologists’ Views of Shared Decision Making for Patients with Inflammatory Bowel Disease
por: Siegel, Corey A., et al.
Publicado: (2015)

Variation in Inflammatory Bowel Disease Care among Saudi Pediatric Gastroenterologists
por: Al-Sarkhy, Ahmed A.
Publicado: (2017)

Insufficient Knowledge of Korean Gastroenterologists Regarding the Vaccination of Patients with Inflammatory Bowel Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany
por: Sullivan, Emma, et al.
Publicado: (2017)

Surfing the web as a patient with IBD: New horizons
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2023)

Perspectives on endoscopic surveillance of dysplasia in inflammatory bowel disease: a survey of academic gastroenterologists
por: Gallinger, Zane R., et al.
Publicado: (2017)

Very Early-Onset Inflammatory Bowel Disease: A Challenging Field for Pediatric Gastroenterologists
por: Arai, Katsuhiro
Publicado: (2020)

Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2021)

Attitudes and Knowledge of Australian Gastroenterologists Around the Use of Medicinal Cannabis for Inflammatory Bowel Disease
por: Benson, Melissa J, et al.
Publicado: (2020)

Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study
por: Mauriz-Barreiro, Violeta, et al.
Publicado: (2023)

How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data
por: Gutiérrez, Ana, et al.
Publicado: (2021)

Contrasting Perspectives of Anesthesiologists and Gastroenterologists on the Optimal Time Interval between Bowel Preparation and Endoscopic Sedation
por: Agrawal, Deepak, et al.
Publicado: (2015)

Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease
por: van Mierlo, Trevor, et al.
Publicado: (2015)

A cross-sectional survey of Saudi gastroenterologists: Transition strategies for adolescents with inflammatory bowel disease
por: Al-Jahdali, Elaf, et al.
Publicado: (2017)

The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists
por: Chan, Walter W., et al.
Publicado: (2022)

Clean mucosal area detection of gastroenterologists versus artificial intelligence in small bowel capsule endoscopy
por: Ju, Jeongwoo, et al.
Publicado: (2023)

Managing ulcerative colitis after surgery
por: Calvino-Suarez, Cristina, et al.
Publicado: (2023)

Subclinical bowel inflammation increases healthcare resources utilization and steroid use before diagnosis of inflammatory bowel disease
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Split-dose bowel preparation improves adequacy of bowel preparation and gastroenterologists’ adherence to National Colorectal Cancer Screening and Surveillance Guidelines
por: Menees, Stacy Bartnik, et al.
Publicado: (2018)

Modifying the natural history of gastrointestinal diseases in Europe as a result of early diagnosis: From eosinophilic esophagitis to inflammatory bowel disease
por: Molina‐Infante, Javier, et al.
Publicado: (2022)

Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses
por: Strohl, Matthew, et al.
Publicado: (2017)

Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease
por: Almasry, Mazen, et al.
Publicado: (2023)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Clinical Management after Endoscopic Submucosal Dissection for Early Gastric Cancer: Sticking to the Gastroenterologist May Be the Best Option!
por: Barreiro, Pedro, et al.
Publicado: (2017)

Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study
por: Canavan, Caroline, et al.
Publicado: (2015)

Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists
por: Lenhart, Adrienne, et al.
Publicado: (2018)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2aldc378dm1bvlqnv8gm9asamo